DiaMedica Therapeutics (DMAC) Change in Cash: 2017-2024
Historic Change in Cash for DiaMedica Therapeutics (DMAC) over the last 8 years, with Dec 2024 value amounting to -$1.5 million.
- DiaMedica Therapeutics' Change in Cash fell 106.64% to -$858,000 in Q4 2019 from the same period last year, while for Dec 2019 it was -$12.9 million, marking a year-over-year decrease of 183.65%. This contributed to the annual value of -$1.5 million for FY2024, which is 720.54% down from last year.
- Per DiaMedica Therapeutics' latest filing, its Change in Cash stood at -$1.5 million for FY2024, which was down 720.54% from -$185,000 recorded in FY2023.
- DiaMedica Therapeutics' 5-year Change in Cash high stood at $3.5 million for FY2020, and its period low was -$2.7 million during FY2021.
- Its 3-year average for Change in Cash is -$560,667, with a median of -$185,000 in 2023.
- As far as peak fluctuations go, DiaMedica Therapeutics' Change in Cash soared by 127.25% in 2020, and later plummeted by 980.95% in 2023.
- Over the past 5 years, DiaMedica Therapeutics' Change in Cash (Yearly) stood at $3.5 million in 2020, then crashed by 176.63% to -$2.7 million in 2021, then soared by 100.78% to $21,000 in 2022, then plummeted by 980.95% to -$185,000 in 2023, then slumped by 720.54% to -$1.5 million in 2024.